14 statements
· 2 topics
· summaries given as host listed separately
Featured statements
▶Ep 3 · 9:40
In severe asthma, MDI with spacer can be effective if the patient can generate adequate inspiratory flow (at least 40 liters per minute) and the spacer valve functions properly.
Second-line therapies for severe asthma include intravenous magnesium sulfate, high-flow nasal cannula oxygen, and intravenous bronchodilators (salbutamol or terbutaline).
Pain assessment scales validated in calm research settings perform poorly in the chaotic emergency department environment, especially for children under 5 years of age
clinicalPain assessment scales validated in calm research settings perform poorly in the chaotic emergency department environment, especially for children under 5 years of age↗
▶Ep 16 · 14:10
quotelas escalas que que quesecontamos tilisamos sun escalas quest validadas perrostam validadas in in in centos the song escalas quiaquecono ferum poco alas utilisado previamente quescuando mejoredimentodan y inventorno was tranquilo↗
▶Ep 16 · 15:00
clinicalBoth families and healthcare professionals systematically underestimate children's pain severity compared to child self-report on validated scales↗
▶Ep 16 · 45:00
clinicalWhen pediatricians do prescribe opioids, evidence indicates they tend to use doses below recommended levels↗
Reunión de la Medicina de Emergencia - Controversias en el manejo del asma grave en urgencias
▶Ep 3 · 9:40
clinicalIn severe asthma, MDI with spacer can be effective if the patient can generate adequate inspiratory flow (at least 40 liters per minute) and the spacer valve functions properly.↗
▶Ep 3 · 12:30
clinicalIpratropium has a good safety profile with minimal side effects compared to other bronchodilators.↗
▶Ep 3 · 14:10
clinicalSecond-line therapies for severe asthma include intravenous magnesium sulfate, high-flow nasal cannula oxygen, and intravenous bronchodilators (salbutamol or terbutaline).↗
▶Ep 3 · 15:00
clinicalThe choice and timing of second-line therapies depend on the patient's response to first-line treatment and the severity of presentation.↗
▶Ep 3 · 18:03
clinicalIntravenous magnesium sulfate is used when the patient does not respond adequately to initial bronchodilators and corticosteroids.↗
▶Ep 3 · 18:30
clinicalHigh-flow nasal cannula oxygen improves patient comfort and may reduce the need for intubation in severe asthma.↗
▶Ep 3 · 41:01
clinicalHigh-flow nasal cannula oxygen is increasingly used as a comfort measure and to delay or avoid intubation in severe asthma.↗
▶Ep 3 · 41:30
clinicalThe availability of ICU beds and airway management expertise influences the threshold for escalating to mechanical ventilation.↗
▶Ep 3 · 45:37
opinionLack of uniform severity definitions and treatment protocols across institutions makes it difficult to conduct high-quality comparative studies of second-line therapies in severe asthma.↗
▶Ep 3 · 46:40
opinionFuture research should focus on developing uniform criteria for defining critical asthma and respiratory failure to enable better evidence generation for second-line treatments.↗
Summaries Javier gave as host
· 2 summaries
Recaps of other experts' statements, not Javier's own clinical position.
Reunión de la Medicina de Emergencia - Controversias en el manejo del asma grave en urgencias
▶Ep 3 · 8:58
host summaryJavier Benito summarizing the discussion: Meta-analyses and large studies show that metered-dose inhalers with spacers are as effective as nebulization in mild-to-moderate asthma exacerbations.↗
▶Ep 3 · 11:42
host summaryJavier Benito summarizing the discussion: Adding ipratropium bromide to salbutamol in the first-line treatment of severe asthma reduces hospital admission rates, particularly in children over 5 years of age.↗
